Dong Sung Bio Pharm.Co.,Ltd. [002210.KS] Stock Forecast

Dong Sung Bio Pharm.Co.,Ltd. engages in the pharmaceuticals, cosmetics, hair dye, and photodynamic therapy businesses in South Korea. It offers OTC drugs, such as liver disease treatment, climacterium, skin disease, obesity, digestive, gingival, alopecia, antipyretic, analgesic, anti-inflammatory, respiratory, scar-recovery, sleep inducer, antidiarrhotica, antiemetic, antiviral, blood circulation enhancer, antifungal, and anti-histamine drugs, as well as keratin softeners, optic nutrition supplements, and vitamins. The company also provides ETC drugs, including endocrine, gastrointestinal, circulatory, neuropsychologic, tumor, analgesic/anti-inflammation, dermato-urinary, anti-viral, antibiotic, antifungal, anti-histamine, and respiratory drugs, as well as steroids and eye drops. In addition, it offers hair dyeing agents, health functional foods, medical devices, daily supplies, muscle taping products, disinfectants, toothpastes, anti-hair loss and hair increase shampoos, sanitary pads, and other products. The company was founded in 1957 and is headquartered in Seoul, South Korea.